Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.60
-0.60 (-4.23%)
At close: Sep 11, 2026

Genomics BioSci & Tech. Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
718.16708.38517.58396.14419389.97
Revenue Growth
20.11%36.86%30.65%-5.46%7.45%-12.01%
Gross Profit
202.65231.36157.18119.91136.01109.92
Operating Income
-129.52-84.16-140.29-81.9-33.52-28.66
Net Income
-25.7-39.43-223.1-168.0771.618.74
Earnings Per Share
-0.35-0.54-3.08-2.361.130.31
EPS Growth
----267.48%3103.13%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Genetic Testing Department
549.06519.86517.58397.18419389.97
Adjustment and Eliminations
0.4-3.4--1.03--
Instrument Sales Department
168.7191.92----
Total
718.16708.38517.58396.14419389.97

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
177.87172.9237.58253.03317107.5
Total Debt
537.39628.25507.67283.61228.8486.53
Net Cash (Debt)
-359.52-455.35-270.08-30.5888.1720.96
Net Cash Growth
----320.57%-95.42%
Net Cash Per Share
-4.89-6.29-3.73-0.431.390.35

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-68.87-86.79-111.77-96.02-21.13-27.76
Capital Expenditures
-23.23-73.49-193.62-150.26-94.08-93.59
Free Cash Flow
-92.1-160.28-305.39-246.28-115.21-121.35
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
28.22%32.66%30.37%30.27%32.46%28.19%
Operating Margin
-18.04%-11.88%-27.11%-20.67%-8.00%-7.35%
Pretax Margin
-7.74%-9.55%-45.47%-42.39%17.25%3.10%
Profit Margin
-3.58%-5.57%-43.10%-42.43%17.09%4.81%
FCF Margin
-12.82%-22.63%-59.00%-62.17%-27.50%-31.12%

Dividends

Fiscal YearFY 2022
Period EndingDec '22
Dividend Per Share
0.098
Dividend Per Share Growth
-
Dividend Yield
0.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----17.5660.09
PS Ratio
1.512.632.693.803.002.89